{"title": "Toxicidad precl\u00ednica del candidato vacunal conjugado anti-pneumoc\u00f3ccico PCV7-TT cubano", "author": "Yana Gonz\u0160lez Torres; Yilian Luque-Mart\u016anez; Axel Mancebo-Rodr\u016aguez; Erick Acosta Lago; Avelina Le\u016fn Go\u016ei; Diuris Blanco Games; Consuelo Gonz\u0160lez Triana; Dasha Fuentes Morales; Marivy Guti\u0165rrez Machado; Iliana Sosa Test\u0165; Sahilis S\u0160nchez Sterling; Laura Rodr\u016aguez Noda; Vicente Verez Bencomo; Yuri Vald\u0165s Balbin; Dagmar Garc\u016aa Rivera; Reynaldo Oliva Hern\u0160ndez", "url": null, "hostname": null, "description": null, "sitename": "Biotecnolog\u016aa Aplicada", "date": "2009-09-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "2021, N\u00famero 1\nBiotecnol Apl 2021; 38 (1)\nToxicidad precl\u016anica del candidato vacunal conjugado anti-pneumoc\u016fccico PCV7-TT cubano\n[ ](addFavorito.php?idArt=103948&idPub=9741)\nGonz\u0160lez TY, Luque-Mart\u016anez Y, Mancebo-Rodr\u016aguez A, Acosta LE, Le\u016fn GA, Blanco GD, Gonz\u0160lez TC, Fuentes MD, Guti\u0165rrez MM, Sosa TI, S\u0160nchez SS, Rodr\u016aguez NL, Verez BV, Vald\u0165s BY, Garc\u016aa RD, Oliva HR\nIdioma: Ingles.\nReferencias bibliogr\u00e1ficas: 26\nPaginas: 1211-1216\nArchivo PDF: 507.07 Kb.\nRESUMEN\nStreptococcus pneumoniae es el agente causal principal de neumon\u016aa bacteriana, otitis media, meningitis y septicemia en ni\u016eos y ancianos. La Organizaci\u016fn Mundial de la Salud considera a esta bacteria como un problema de salud significativo para varios pa\u016ases. Los pneumococos incluyen a una serie de bacterias comensales altamente adaptadas, cuyo reservorio principal es la superficie mucosal de las v\u016aas respiratorias superiores de los portadores, lo cual facilita su transmisi\u016fn. Por lo tanto, las vacunas confieren una importante protecci\u016fn. Por tales razones, se ha desarrollado el nuevo candidato vacunal conjugado heptavalente PCV7-TT contra la enfermedad pneumoc\u016fccica. En este trabajo, se realiz\u016f una prueba de dosis repetida y tolerancia local al PCV7-TT en ratas Sprague Dawley, como parte de los estudios de toxicidad precl\u016anica. Los animales recibieron cuatro dosis de la vacuna por la v\u016aa intramuscular a tres niveles de concentraci\u016fn. Se les evalu\u016f durante 43 d\u016aas a intervalos de 14 d\u016aas, y se les realiz\u016f la observaci\u016fn cl\u016anica, y se les determin\u016f el peso corporal, la temperatura, los par\u0160metros hematol\u016fgicos, la qu\u016amica sangu\u016anea y los estudios patol\u016fgicos. No se observaron s\u016antomas cl\u016anicos ni ocurri\u016f la muerte de los animales ensayados. Solo hubo una ligera inflamaci\u016fn y endurecimiento en el sitio de la inmunizaci\u016fn. Tampoco hubo cambios significativos en el peso corporal, la temperatura, la hematolog\u016aa ni en la qu\u016amica sangu\u016anea. No se observ\u016f cambios patol\u016fgicos en los \u016frganos; solo hubo una respuesta local en forma de reacci\u016fn inflamatoria cr\u016fnica similar a la de otras vacunas que incluyen en su composici\u016fn a sales de aluminio como adyuvante. En consecuencia, el candidato vacunal PCV-TT fue potencialmente seguro y tolerable para su posible administraci\u016fn en humanos.\nREFERENCIAS (EN ESTE ART\u00cdCULO)\nO\u00edBrien KL. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893-902.\nWorld Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper. No 8, 2019, 94, 85-104. 2019 (cited 2020 Oct 14). Available from: https://www.who.int/wer/en/.\nWang SA, Mantel CF, Gacic-Dobo M, Dumolard L, Cherian T, Flannery B, et al. Progress in introduction of pneumococcal conjugate vaccine. Morbidity Mortality Weekly Report. 2013;62(16):308-311.\nJohnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: The Pneumococcal Global Serotype Project. PLoS Med 2010;7(10): e1000348.\nCasta\u016eeda E, Agudelo CI, Regueira M, Corso A, Brandileone MC, Brand\u201eo AP, et al. Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA II project, 2000-2005. Pediatr Infect Dis J. 2009;28:e265-70.\nWorld Health Organization. Guidelines on nonclinical evaluation of vaccine. Technical Report Series, No. 927. Geneva: WHO; 2005 (cited 2020 Sep 17). Available from: http://www.who.int/biologicals/ vaccines/nonclinical_evaluation_of_vaccines/ en/.\nEuropean Medicine Agency. ICH/286/95. Note for guidance on nonclinical safety studies for the conduct of human clinical trials for pharmaceuticals. ICH M3 (R2). London: EMEA; 2008 (cited 2020 Sep 17). Available from: http://www. ema.europa.eu/docs/en_GB/document_ library/Scientific_guideline/2009/09/ WC500002941.pdf.\nFood and Drug Administration. Considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications U.S. Silver Spring: Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research February; 2006.\nMorton DB. Humane endpoints in animal experimentation for biomedical research: ethical, legal and practical aspect. Laboratory animals 2005;8:5-12.\nFranco NH. Animal Experiments in Biomedical Research: A Historical Perspective. Animals. 2013; 3(1):238-273.\nCanadian Council on Animal Care. Guidelines on: Euthanasia of animals used in science. Ottawa: CCAC; 2010.\nLABTOOLS. Centro de Investigaciones y Evaluaciones Biol\u016fgicas, Instituto de Farmacia y Alimentos. Versi\u016fn 2.0. 1996.\nDiehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumen. J Appl Toxicol. 2001;21:15-23.\nOliva R, Fraleigh NL, Lewicky JD, Fari\u016eas M, Hern\u0160ndez T, Martel AL, et al. Repeat-dose toxicity study using the AFPL1-conjugate nicotine vaccine in male Sprague Dawley rats. Pharmaceutics. 2019;11:626.\nDiPasquale L, Hayes W. Principles of Clinical Patology for Toxcicology Studies. In: Hayes\u00ed Principles and Methods of Toxicology. (Sixth edition). Wallace Hayes A, Kruger C. New York: CRC Press Taylor and Francis Group; 2014. p. 1305-44.\nGreaves P. Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation. New York: Academic Press; 2011.\nMicrosoft Corporation. Statistical Package Scientific System, SPSS for Windows, Copyright SPSS Inc., 2002.\nWeber K, Razinger T, Hardisty JF, Mann P, Martel KC, Frische EA, et al. Differences in rat models used in routine toxicity studies. Int J Toxicol. 2011;30(2):162-173.\nOliva R, Fari\u016eas M, Infante JF, Hern\u0160ndez T, P\u0165rez Y, Oyarzabal A, et al. Single dose toxicity study of polysaccharide VI conjugate vaccine in Sprague Dawley rats. Biomed J Sci Tech Res. 2019;23(4):17592- 9.\nOliva-Hern\u0160ndez R, Bourzac-Infante JF, Garc\u016aa-Imias, Garc\u016aa-S\u0160nchez HM L, Cedr\u0165-Marrero B, Gonz\u0160lez-Sierra VG. Ensayo de inmunogenicidad y toxicidad aguda del candidato vacunal contra el c\u016flera vax-COLER. VacciMonitor. 2020;29(1):22-30.\nOliva-Hern\u0160ndez R, Fari\u016eas-Medina M, Hern\u0160ndez-Salazar T, Infante-Bourzac JF, N\u0137\u016eez-Mart\u016anez D, Quintero-P\u0165rez A, et al. Single dose toxicity non-clinical evaluation of the anti-meningococcal vaccine VA-MENGOC-BC\u0123 in Sprague Dawley rats to extend its shelf-life to 36 months. Biotecnol Apl. 2018;35(3):3211-5.\nTaconic Technical Library. Taconic Sprague Dawley. Growth and Phenotyping Data. April 2004 (cited 2020 Sep 17). Available in: http://www.taconic.com/rat-model/ sprague-dawley.\nGo\u016ei ACL, Blanco D, Pe\u016ea A, Ronda M, Gonz\u0160lez BO, Arteaga ME, et al. Valores hematol\u016fgicos y bioqu\u016amicos de las ratas Sprague Dawley producidas en CENPALAB, Cenp: SPRD. Rev Electr\u016fn Vet. 2011;12(11):1-10.\nGuti\u0165rrez A, G\u0160mez R, Noa M, Mas R, Arencibia D, et al. One year oral Toxicity of D-004, a lipid extract from Roystonea regia fruits, in Sprague Dawley rats. Food Chem Toxicol. 2011 Nov;49(11):2855-61.\nTamargo B, Bungau S, Fleitas C, M\u0160rquez Y, Infante JF, Oliva R, et al. Immuno-toxicological evaluation of the adjuvant formulations for experimental anti-meningococcal vaccines without aluminium hydroxide. Rev. Chim. (Bucharest) 2019;70(4):1251-75.\nBacardi D, Cosme K, Aldana L, Merino N, Su\u0160rez J, Mosqueda O, et al. Preclinical safety testing of the Quimi-Hib\u0123 vaccine adjuvanted with aluminum phosphate during product development. Biotecnol Apl. 2013;30(2):118-24.", "language": null, "image": null, "pagetype": null, "links": ["https://www.medigraphic.com/", "resumenI.cgi?IDARTICULO=103948", "#", "https://www.medigraphic.com/cgi-bin/new/publicaciones.cgi?IDREVISTA=281", "https://www.medigraphic.com/cgi-bin/new/contenido.cgi?IDPUBLICACION=9741", "https://www.medigraphic.com/cgi-bin/new/publicaciones.cgi?IDREVISTA=281", "#", "https://www.medigraphic.com/cgi-bin/new/informacion.cgi?IDREVISTA=281", "https://www.medigraphic.com/cgi-bin/new/directorio.cgi?IDREVISTA=281", "#", "https://www.medigraphic.com/cgi-bin/new/instrucciones.cgi?IDREVISTA=281", "https://www.medigraphic.com/", "https://www.medigraphic.com/", "https://www.medigraphic.com/cgi-bin/new/medigraphic.cgi", "#", "#", "#", "#", "addFavorito.php?idArt=103948&idPub=9741", "https://www.medigraphic.com/pdfs/biotecapl/ba-2021/ba211c.pdf", "#", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null]}